Lithium Protects Against Anaesthesia Neurotoxicity In The Infant Primate Brain

Kevin K Noguchi1, Stephen A Johnson1, Lauren E Kristich1

  • 1Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, US.

Scientific Reports
|March 9, 2016
PubMed

Insights

Lithium protects infant non-human primates from anesthesia-induced brain cell death. This finding suggests a potential strategy to prevent long-term neurodevelopmental impairment in infants exposed to anesthesia.

Area of Science:

  • Neuroscience
  • Developmental Neuroscience
  • Pharmacology

Background:

  • Anesthetic drug exposure in infant animals and humans is linked to neurodevelopmental impairment (NDI).
  • Millions of infants undergo anesthesia annually, raising concerns about potential long-term cognitive deficits.
  • Lithium (Li) demonstrates neuroprotective effects in various brain injury models.

Purpose of the Study:

  • To investigate the neuroprotective potential of lithium against anesthesia-induced neurotoxicity in infant non-human primates (NHPs).
  • To determine if lithium can prevent apoptosis of neurons and oligodendrocytes caused by isoflurane anesthesia.

Main Methods:

  • Infant NHPs were administered isoflurane (ISO) anesthesia for 5 hours on postnatal day 6.
  • Co-administration of clinically relevant doses of lithium (Li) was given alongside isoflurane.
  • Apoptosis of neurons and oligodendrocytes was assessed post-anesthesia.

Main Results:

  • Lithium completely prevented acute isoflurane-induced neuroapoptosis in infant NHPs.
  • Lithium significantly reduced isoflurane-induced apoptosis of oligodendrocytes.
  • These results indicate a neuroprotective effect of lithium against anesthetic neurotoxicity.

Conclusions:

  • Lithium shows promise as a neuroprotective agent against anesthetic-induced brain injury in developing primates.
  • Pharmacological manipulation with lithium may safeguard the developing brain from anesthetic neurotoxicity without compromising anesthetic efficacy.
  • Further research is warranted to confirm lithium's efficacy in preventing long-term NDI and assess its safety in human infants.